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Objectives: Recent randomized controlled trials have
shown that age significantly affects the outcome of carotid
revascularization. The purpose of this study is to utilize data
from the SVS Vascular Registry® (VR) to report the influ-
ence of age on the comparative effectiveness of CEA and
CAS.
Methods: VR collects provider-reported patient-data
using a web-based database. Patients were stratified based
on age and symptomatology. The primary endpoint was the
composite of death, stroke and myocardial infarction (MI)
at 30-days.
Results: As of 12/7/10, there were 1347-CEA and
861-CAS 65 years and 4169-CEA and 2536 CAS
65years. In both age groups, CAS was more likely to
have radiation or restenosis for disease etiology, be symp-
tomatic, and have higher cardiac comorbidities. In
65years, CAS had higher rates of mortality (1.97% vs
0.91%, p0.01), stroke (4.89% vs 2.52%, p0.01) and the
combined death/stroke/MI (7.14% vs 4.27%, p0.01). In
65years, the primary endpoint (5.23% CAS vs 3.56%
CEA, p0.065) approached statistical significance. Further
analyses showed that CAS in 65years was associated
with higher primary outcome rate in both symptomatic
(9.52% vs 5.27%, p0.01) and asymptomatic (5.27% vs
3.31%, p0.01) subgroups. For 65years, CAS had
higher combined death/stroke/MI (4.44% vs 2.10%,
p0.031) in asymptomatics but no difference in symp-
tomatics (6.00% vs 5.47%, p0.79). After risk adjust-
ment (Table 1), CAS. 65years were more likely to
reach the primary endpoint
Conclusions: Compared to CEA, CAS resulted in
inferior 30-day outcomes in symptomatic and asymptom-
atic patients 65years.
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Objectives: The objectives of this study were to define
variables that predict failure of femoral access for mesen-
teric arterial intervention. We evaluated the relationship
between anatomical and mural characteristics of the mes-
enteric vessels to determine the optimal access site for
successful percutaneous intervention.
Methods: A prospective database identified all pa-
tients who underwent an endovascular mesenteric inter-
vention from 2005-2010. Patient demographics, lesion
characteristics and operative details were analyzed. All
angiograms were reviewed for mesenteric vessel angula-
tion, tortuosity, lesion severity, and calcium score to
determine the necessary access site for intervention. All
patients had an initial attempt made through femoral
access (F), followed by brachial access (B) if technical
success was not achieved.
Results: 142 mesenteric arteries in 125 patients were
reviewed. Of these, 83 vessels underwent endovascular
treatment (50 Celiac, 33 SMA). The majority of these
patients were female (n57). 22 lesions were treated for
aneurysm (15 celiac, 7 SMA) and 61 for CMI (12%
CTO). 58 lesions were treated with F, while 24 required
B. Mean angulation of the mesenteric arteries requiring
F access was 48 degrees / 15 and 40 / 18 for
brachial (P0.03). Calcification at the origin did not
impact access site (22% F- severe calcium score; 14% B;
P.5). Presence of CTO predicted brachial route (24% B
vs 3.4% F, P.008). Complication rates (arterial repair,
hematoma) were higher in the B group (16% B vs 4% F,
P.05).
Conclusions: Severe angulation and CTO are associ-
ated with technical failure for mesenteric intervention via
transfemoral route. This is the first study to define factors
where brachial access is the optimal approach for a success-
ful endovascular intervention.
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